---

| Thursday, December 19th | 0 comments

Herantis Pharma Plc completes patient treatments in main study of Phase 1-2 CDNF trial in Parkinson’s disease

https://herantis.com/press_releases/herantis-pharma-plc-completes-patient-treatments-in-main-study-of-phase-1-2-cdnf-trial-in-parkinsons-disease/

---